HARMONY BIOSCIENCES HLDG INC (HRMY) — insider trading
Health Care · NASDAQ
HARMONY BIOSCIENCES HLDG INC (HRMY) has 37 reported SEC Form 4 insider transactions in our data, including 7 open-market sales among the most recent 37 (latest 2026-09-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 25,446 | — | $0 | Form 4 |
| 2026-09-18 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 10,406 | — | $0 | Form 4 |
| 2026-09-18 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 35,852 | $43.05 | $1.54M | Form 4 |
| 2026-09-18 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 25,446 | $30.27 | $770.3K | Form 4 |
| 2026-09-18 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 10,406 | $30.69 | $319.4K | Form 4 |
| 2026-09-17 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 400 | — | $0 | Form 4 |
| 2026-09-17 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 400 | — | $0 | Form 4 |
| 2026-09-17 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 800 | $43.00 | $34.4K | Form 4 |
| 2026-09-17 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 400 | $30.27 | $12.1K | Form 4 |
| 2026-09-17 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 400 | $30.69 | $12.3K | Form 4 |
| 2026-09-16 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 900 | — | $0 | Form 4 |
| 2026-09-16 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 900 | — | $0 | Form 4 |
| 2026-09-16 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 1,800 | $43.01 | $77.4K | Form 4 |
| 2026-09-16 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 900 | $30.27 | $27.2K | Form 4 |
| 2026-09-16 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 900 | $30.69 | $27.6K | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 10,754 | — | $0 | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 12,200 | — | $0 | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 22,954 | $43.10 | $989.3K | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 10,754 | $30.27 | $325.5K | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 12,200 | $30.69 | $374.4K | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 1,000 | $42.79 | $42.8K | Form 4 |
| 2026-09-08 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 4,500 | $42.25 | $190.1K | Form 4 |
| 2026-09-04 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Open-market sale | 5,500 | $41.98 | $230.9K | Form 4 |
| 2026-05-14 | Sender Gary | Director | Grant / award / vesting (derivative) | 21,872 | — | $0 | Form 4 |
| 2026-05-14 | Sabater Juan A. | Director | Grant / award / vesting (derivative) | 21,872 | — | $0 | Form 4 |
| 2026-05-14 | Graf R. Mark | Director | Grant / award / vesting (derivative) | 21,872 | — | $0 | Form 4 |
| 2026-05-14 | Philip Ron M | Director | Grant / award / vesting (derivative) | 21,872 | — | $0 | Form 4 |
| 2026-05-14 | Szyper Linda M | Director | Grant / award / vesting (derivative) | 21,872 | — | $0 | Form 4 |
| 2026-05-14 | Germano Geno J | Director | Grant / award / vesting (derivative) | 21,231 | — | $0 | Form 4 |
| 2026-05-01 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion (derivative) | 18,750 | — | $0 | Form 4 |
| 2026-05-01 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Shares withheld for taxes / exercise cost | 8,882 | $31.83 | $282.7K | Form 4 |
| 2026-05-01 | Budur Kumar | Officer (CHIEF MEDICAL OFFICER) | Option exercise / conversion | 18,750 | — | $0 | Form 4 |
| 2026-04-14 | Reicin Glenn | Officer (CHIEF FINANCIAL OFFICER) | Grant / award / vesting (derivative) | 164,309 | — | $0 | Form 4 |
| 2026-04-07 | Zaeske Adam H. | Officer (CHIEF COMMERCIAL OFFICER) | Option exercise / conversion (derivative) | 7,500 | — | $0 | Form 4 |
| 2026-04-07 | Zaeske Adam H. | Officer (CHIEF COMMERCIAL OFFICER) | Shares withheld for taxes / exercise cost | 3,173 | $27.62 | $87.6K | Form 4 |
| 2026-04-07 | Zaeske Adam H. | Officer (CHIEF COMMERCIAL OFFICER) | Option exercise / conversion | 7,500 | — | $0 | Form 4 |
| 2026-04-02 | Anastasiou Peter | Officer (CHIEF OPERATING OFFICER) | Grant / award / vesting (derivative) | 212,241 | — | $0 | Form 4 |
Ask the chat about HRMY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HARMONY BIOSCIENCES HLDG INC (HRMY).
Last updated 2026-09-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.